Condition: COVID-19 · SARS-CoV-2 · Sponsor: Invivyd, Inc.
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or older who are at risk of exposure to SARS-CoV-2
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| INVIVYD Investigative Site | Fullerton, California, United States | — |
| INVIVYD Investigative Site | Long Beach, California, United States | — |
| INVIVYD Investigative Site | Rolling Hills Estates, California, United States | — |
| INVIVYD Investigative Site | San Diego, California, United States | — |
| INVIVYD Investigative Site | Clearwater, Florida, United States | — |
| INVIVYD Investigative Site | Miami, Florida, United States | — |
| INVIVYD Investigative Site | St. Petersburg, Florida, United States | — |
| INVIVYD Investigative Site | Atlanta, Georgia, United States | — |
| INVIVYD Investigative Site | Hinesville, Georgia, United States | — |
| INVIVYD Investigative Site | Oak Brook, Illinois, United States | — |
| INVIVYD Investigative Site | Silver Spring, Maryland, United States | — |
| INVIVYD Investigative Site | Burlington, Massachusetts, United States | — |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06039449